(C-2), 72.3 (C-4), 69.8 (C-3), 67.8 (C-7), 66.3 (C-5), 63.3 (C-6), 51.7 (C-8), 29.6, 19.5 (C(CH 3 ) 2 ) ppm; IR (ATR) ṽ = 3270, 2925, 2101, 1377, 1265, 1196, 1135, 1070, 1025, 853 
2-Azidoethyl 4,6-O-isopropylidene-2,3-di-O-propargyl-α-D-mannopyranoside (3).
A solution of mannoside 2 (450 mg, 1.56 mmol) in dry DMF (10 mL) was treated with sodium hydride (60% in mineral oil, 250 mg, 6.23 mmol) and the reaction mixture stirred for 30 min at rt. Then propargyl bromide (80% in toluene) (1.00 mL, 9.33 mmol) and TBAI (287 mg, 778 μmol) were added and the reaction was stirred overnight at rt. It was quenched by addition of water (20 mL) and the aq phase was extracted with CH 2 Cl 2 (3 × 30 mL). The 3263, 2924, 2878, 2103, 1497, 1451, 1373, 1266, 1199, 1110, 1084, 1059, 1021, 913, 862 
2-Azidoethyl 2,3-di-O-propargyl-α-D-mannopyranoside (4).
The isopropylidene-protected mannoside 3 (300 mg, 821 μmol) was dissolved in CH 2 Cl 2 /TFA (9:1) (5 mL) and the reaction mixture stirred for 10 min at rt. Half-satd. aq Na 2 CO 3 solution (10 mL) was added and the aq phase was extracted with CH 2 Cl 2 (30 mL). The organic phases were combined and dried over 
2-tert-Butoxycarbonylamidoethyl 2,3-di-O-propargyl-α-D-mannopyranoside (5). For
Staudinger reduction, a solution of mannoside 4 (182 mg, 559 μmol) in dry THF (6 mL) was treated with triphenylphospine (220 mg, 839 μmol) and the reaction mixture stirred for 3 h at rt. After addition of water (6 mL) the reaction was stirred rigorously overnight. The solvents were removed under reduced pressure and the residual crude product was taken up in dry 
2-tert-Butoxycarbonylamidoethyl 2,3-di-O-[4-(thymin-N

2-tert-Butoxycarbonylamidoethyl 4,6-O-isopropylidene-2,3-di-O-propargyl-α-Dmannopyranoside (9).
For Staudinger reduction, a solution of mannoside 3 (573 mg, 1.57 mmol) in dry THF (12 mL) was treated with triphenylphosphine (616 mg, 2.35 mmol) and the reaction mixture stirred at rt for 3 h. After addition of water (12 mL) the reaction was stirred rigorously overnight. The solvents were removed under reduced pressure and the crude product was taken up in dry MeOH (12 mL) and after addition of Boc 2 O (514 mg, 2.35 mmol) the reaction mixture was stirred overnight at rt. The solvent was removed under reduced pressure and purification of the crude product by column chromatography (cyclohexane/ethyl acetate, 2:1) gave the title mannoside 9 as a colourless syrup (599 mg, 1.36 mmol, 87% 2935, 1743, 1698, 1641, 1464, 1367, 1218, 1133, 1046, 1034, 767 3366, 2927, 1693, 1661, 1627, 1465, 1366, 1254, 1132, 1054, 768 Figure S22: UV-vis spectra of divalent thymine conjugate 7 (conc. 100 µg/1 mL) and its [2 + 2] photocycloaddition product 8 (isomeric mixture) (conc. 100 µg/1 mL). Figure S25 : UV-vis spectra of divalent glycothymine conjugate 13 (conc. 100 µg/1 mL) and its [2 + 2] photocycloaddition product 14 (isomeric mixture) (conc. 100 µg/1 mL).
2-tert-Butoxycarbonylamidoethyl 4,6-O-isopropylidene-2,3-di-O-[4-(thymin-N 1 -ylpropyl)-triazolylmethyl]-α-D-mannopyranoside (10
2-tert-Butoxycarbonylamidoethyl 4,6-O-isopropylidene-2,3-di-O-{4-[N
